Cargando…

The 1-Year Safety and Efficacy Outcomes of Magmaris, Novel Magnesium Bioresorbable Vascular Scaffolds in Diabetes Mellitus Patients with Acute Coronary Syndrome

Background: Diabetes mellitus (DM) is one of the major risk factors contributing to Acute Coronary Syndromes (ACS) and is associated with an increased risk of adverse clinical outcomes following percutaneous coronary intervention (PCI), even when the second generation of drug-eluting stents (DES) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Włodarczak, Adrian, Łanocha, Magdalena, Szudrowicz, Marek, Barycki, Mateusz, Gosiewska, Alicja, Kulczycki, Jan Jakub, Lesiak, Maciej, Doroszko, Adrian, Rola, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304146/ https://www.ncbi.nlm.nih.gov/pubmed/34300332 http://dx.doi.org/10.3390/jcm10143166

Ejemplares similares

Sex Differences in the Clinical Features and Outcomes of Patients with Acute Coronary Syndrome Treated with Two Generations (Absorb and Magmaris) of Bioresorbable Vascular Scaffolds
por: Włodarczak, Adrian, et al.
Publicado: (2021)

Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents
por: Rola, Piotr, et al.
Publicado: (2021)

Magnesium Bioresorbable Scaffold (BRS) Magmaris vs Biodegradable Polymer DES Ultimaster in NSTE-ACS Population—12-Month Clinical Outcome
por: Rola, Piotr, et al.
Publicado: (2022)

Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds – magmaris in diabetic population. 2-Years outcome in acute coronary syndrome cohort
por: Włodarczak, Adrian, et al.
Publicado: (2023)

Rota-Lithotripsy—A Novel Bail-Out Strategy for Calcified Coronary Lesions in Acute Coronary Syndrome. The First-in-Man Experience
por: Włodarczak, Adrian, et al.
Publicado: (2021)

Rota-lithotripsy: A combination of rotational atherectomy and intravascular lithotripsy (Shockwaves) as a novel strategy for a rotablation-resistant lesion in a patient with ST-segment elevation myocardial infarction
por: Włodarczak, Adrian, et al.
Publicado: (2021)

Intravascular Lithotripsy as a Novel Treatment Method for Calcified Unprotected Left Main Diseases—Comparison to Rotational Atherectomy—Short-Term Outcomes
por: Rola, Piotr, et al.
Publicado: (2022)

Shockwave intravascular lithotripsy as a novel strategy for balloon undilatable heavily calcified chronic total occlusion lesions
por: Rola, Piotr, et al.
Publicado: (2023)

Efficacy and safety of shockwave intravascular lithotripsy (S-IVL) in calcified unprotected left main percutaneous coronary intervention – short-term outcomes
por: Rola, Piotr, et al.
Publicado: (2021)

Rota-Lithotripsy as a Novel Bail-Out Strategy for Highly Calcified Coronary Lesions in Acute Coronary Syndrome
por: Rola, Piotr, et al.
Publicado: (2022)

Comparison of Orbital Atherectomy and Rotational Atherectomy in Calcified Left Main Disease: Short-Term Outcomes
por: Rola, Piotr, et al.
Publicado: (2023)

Use of the Shock Wave Therapy in Basic Research and Clinical Applications—From Bench to Bedsite
por: Rola, Piotr, et al.
Publicado: (2022)

“All hands on deck” – rota-lithotripsy – a combination of rotational atherectomy and intravascular lithotripsy (shockwave) with additional use of a Turnpike Gold microcatheter and guide extension as a novel approach for calcified lesions
por: Rola, Piotr, et al.
Publicado: (2021)

Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)

Safety and Efficacy of Orbital Atherectomy in the All-Comer Population: Mid-Term Results of the Lower Silesian Orbital Atherectomy Registry (LOAR)
por: Rola, Piotr, et al.
Publicado: (2023)

First experience with orbital atherectomy in calcified unprotected left main percutaneous coronary intervention
por: Rola, Piotr, et al.
Publicado: (2022)

Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario
por: Boeder, Niklas F., et al.
Publicado: (2021)

Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients’ Population
por: Al Nooryani, Arif, et al.
Publicado: (2022)

BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients
por: Verheye, Stefan, et al.
Publicado: (2020)

Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?
por: Jeżewski, Mateusz P., et al.
Publicado: (2019)

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013)

Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation
por: Opolski, Maksymilian P., et al.
Publicado: (2018)

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
por: Bossard, Matthias, et al.
Publicado: (2022)

“Leaving nothing behind”: is the bioresorbable vascular scaffold a new hope for patients with coronary artery disease?
por: Lesiak, Maciej, et al.
Publicado: (2014)

In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications
por: Menze, Roman, et al.
Publicado: (2021)

Mid-term safe and effective profile of the Magmaris scaffold in percutaneous coronary intervention: a prospective, single-center study
por: Truong, Binh Quang, et al.
Publicado: (2023)

Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study
por: Barkholt, Trine Ø., et al.
Publicado: (2021)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry
por: Rzeszutko, Łukasz, et al.
Publicado: (2016)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Effect of the transdermal low-level laser therapy on endothelial function
por: Szymczyszyn, Alicja, et al.
Publicado: (2016)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6feoqmjfd7m70ke2c09200tdq